COVID-19: Vaccines and Therapeutics
The Centers for Disease Control and Prevention last week endorsed a recommendation from the Advisory Committee on Immunization Practices for people aged 65 and older along with individuals moderately or severely immunocompromised to receive a second dose of the 2024-2025 COVID-19 vaccine six months…
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their patients safe during respiratory virus season.
Autumn is here, and that means cooler weather and also the start of flu season.
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a family member getting a respiratory virus infection this fall and winter.
Child and Adolescent Health Care: VaccinesVaccines prevent kids from contracting viruses.
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests.
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25.
Stay up-to-date on the safety of COVID-19 vaccines with the recent evidence review released by the National Academies of Sciences, Engineering, and Medicine. Learn about the potential side effects of the Pfizer and Moderna vaccines, including myocarditis.
Funded Partnerships fosters transformative health care collaborations supported by AHA and its 501c3, the Health Research & Educational Trust (HRET).
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices that adults ages 65 years and older receive an additional updated 2023-2024 COVID-19 vaccine dose.